StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report published on Tuesday morning. The firm issued a hold rating on the stock.
TherapeuticsMD Stock Up 0.6 %
TherapeuticsMD stock opened at $1.59 on Tuesday. The stock has a 50-day moving average price of $1.69 and a 200 day moving average price of $1.82. TherapeuticsMD has a 52 week low of $1.43 and a 52 week high of $3.07.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.23 million for the quarter.
Institutional Trading of TherapeuticsMD
TherapeuticsMD Company Profile
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Further Reading
- Five stocks we like better than TherapeuticsMD
- Why Are These Companies Considered Blue Chips?
- Texas Roadhouse Stock Steering for New Highs This Year
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- 3 Fintech Stocks With Good 2021 Prospects
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.